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Abstract 
The aim of this study was to characterize two
monoclonal antibodies (F6A11 and F109-D12)
generated against Pdx1 (pancreatic and duode-
nal homeobox-1), a homeodomain transcription
factor, which is critical for pancreas formation
as well as for normal pancreatic beta cell func-
tion. For production of monoclonal antibodies,
we immunized Robertsonian POSF (RBF)mice
with a GST-Pdx1 fusion protein containing a 68-
amino  acid  C-terminal  fragment  of  rat  Pdx1.
These  monoclonal  antibodies  detect  Pdx1  by
western blotting and allow immunohistochemi-
cal detection of Pdx1 in both mouse and rat tis-
sue. F6A11 and F109-D12 produce IHC staining
patterns indistinguishable from that obtained
with  highly  specific  polyclonal  Pdx1  antisera
raised  in  rabbits  and  goats,  when  applied  to
embryonic or adult mouse pancreatic tissue. In
contrast to previously generated polyclonal anti-
Pdx1 antisera, we also demonstrate that F6A11
works  for  intracellular  fluorescence  activated
cell sorting (FACS) staining of Pdx1. By using
F6A11, we characterize the induction of Pdx1 in
the  Doxycycline  (DOX)  inducible  insulinoma
cell line INSrαβ-Pdx1 and follow the reduction
of Pdx1 after removing Dox. Finally, we show
that  induction  of  exogenous  Pdx1  leads  to  a
reduction  in  endogenous  Pdx1  levels,  which
suggests  that  a  negative  feedback  loop  is
involved in maintaining correct levels of Pdx1 in
the cell. 
Introduction
The pancreatic duodenal homeobox gene 1,
Pdx1, encodes a key regulatory factor required
for  pancreatic  development  in  mouse
1,2 and
man,
3 as  well  as  for  normal  β-cell  function
including  glucose-regulated  insulin  produc-
tion.
4,5 In the adult pancreas, high levels of Pdx1
expression  are  primarily  restricted  to  insulin
producing  β-cells,  and  the  protein  was  first
identified and characterized as an insulin gene
trans-activating factor.
6,7 In the mature β-cell,
Pdx1 is involved in glucose regulated insulin
gene  transcription
8 and  mutations  in  PDX1
cause  maturity  onset  diabetes  of  the  young
(MODY).
9
Pdx1 expression begins at embryonic day 8.5
(e8.5) in two ventro-lateral domains, before clo-
sure  of  the  foregut  endoderm.  Slightly  later
(~e8.75) a dorsal expression domain appears at
the level of somites 4 to 7. Until around e9.5,
Pdx1 expression is restricted to the pancreatic
buds, but from around e10.5 the Pdx1-expres-
sion domain expands to include the duodenum,
the pyloric region and the antral stomach.  
From  e13.5-15.5,  Pdx1  expression  levels
decline  in  the  forming  acinar  cells,  while
remaining more broadly expressed throughout
the  developing  ductal  tree,  where  high-level
Pdx1- and Nkx6.1-expression marks the form-
ing  β-cells.
2,7,10,11 As  the  islets  begin  to  form
around  e18.5,  expression  of  Pdx1  becomes
localized primarily to the β-cells.
Selective inactivation of Pdx1 expression in
β-cells leads to loss of these and to diabetes.
4,12
Furthermore, timed inactivation of Pdx1 expres-
sion  during  mouse  pancreas  development
demonstrates Pdx1-requirement also for normal
acinar  development  and  maintenance  of  the
exocrine  transcription  factor  Ptf1a.
5 Addition  -
ally, several target genes have been identified
for Pdx1, including the insulin gene,
8 Nkx6.1,
13
GLUT-2,
14 IAPP,
15,16 glucokinase
14,16 as  well  as
somatostatin,
17,18 exocrine  genes  such  as
Elastase1
19 and finally also Pdx1 itself.
20,21
The  rat  α/β-cell  hybrid  subclone  INSrαβ-
Pdx1 has been generated with the aim to fur-
ther study Pdx1 regulated genes and the role of
Pdx1 in β-cell maturation. In this cell line Pdx1
levels are under the control of the reverse tetra-
cycline-dependent transactivator (rtTA).
22 This
INSrαβ-Pdx1 cell line has been used to identify
genes with potential functional significance in
type 1 diabetes (T1D),
23,24 to study insulin pro-
cessing and secretion
25,26 and to elucidate the
role of Pdx-1 in β-cell maturation and acquired
IL-1β-mediated toxicity.
24 However, the details
of the dynamic induction of Pdx1 in this impor-
tant model system are not known, as well as the
effects of expressing high levels of exogenous
Pdx1 protein on the endogenous Pdx1 protein
levels.  By  help  of  a  more  detailed  biological
understanding of the system, more conclusive
data may be drawn from such experiments. We
used  newly  generated  monoclonal  antibodies
against Pdx1 to study the induction of Pdx1 in
the INSrαβ-Pdx1 cell line and show that induc-
tion of exogenous Pdx1 leads to a reduction in
endogenous Pdx1 levels. This suggests that a
negative feedback loop is involved in maintain-
ing correct levels of Pdx1 in the cell.
Materials and Methods
Expression and purification of GST-
Pdx1 
For immunizations, we cloned a 68 amino
acid C-terminal fragment of the rat Pdx1 tran-
scription  factor  (aa215-283)  as  a  GST  fusion
protein.
27 The C termini of the rat, mouse and
human Pdx1 proteins vary in sequence; the cho-
sen  GST-Pdx1  fusion  protein  have  previously
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allowed us to generate polyclonal antisera that
may  be  either  rat-specific  or  cross-react  to
mouse and/or human Pdx1.
15,28,29 The GST-Pdx1
fusion protein was purified using a Glutathione
Sepharose  4B  Redipack  column  (Amersham
Biosciences, Uppsala, Sweden). 
Immunization
In  order  to  obtain  monoclonal  antibodies,
four RBF-mice
30were immunized i.p.with 20 ʼg
GST-Pdx1 biweekly. The first immunization was
performed  with  complete  Freund’s  adjuvant;
this was followed by two injections in incom-
plete Freund’s adjuvant. Ten days after the third
immunization, the animals were eye-bled and
the antibody response measured by ELISA. In
addition,  specific  staining  of  β-cells  of  adult
mice  pancreatic  tissue  was  determined  by
immunohistochemical  staining.  All  animal
experiments  were  performed  according  to
national guidelines and approved by the nation-
al ethics committee.
Cell fusion
The mouse selected for generation of mono-
clonal antibodies was boosted i.v. with 10 ʼg
antigen in saline. Three days later, the spleen
was harvested and used for hybridoma produc-
tion.  The  1.3ﾥ10
8 spleen  cells  were  fused  to
3.9ﾥ10
7FOX-NY myeloma cells
30using polyethyl-
eneglycol  (PEG)  1500  (Roche,  Hvidovre,
Denmark) as described in a previous study.
31
The fused cells were initially seeded in 96 well
tissue culture plates and the individual clones
tested for the production of anti-Pdx1 antibod-
ies, by ELISA and immunohistochemical stain-
ing. Positive clones were subcloned by limiting
dilution. 
ELISA
ELISA plates were coated O/N with 1 ʼg/mL
GST-Pdx1  or  pure  GST  (Sigma,  Brøndby,
Denmark) in PBS. Washing and blocking was
performed  with  PBS,  0.05%  Tween  20.  Then,
samples were added, after dilution in PBS, 0.5%
Tween 20, 1 M NaCl, pH 7.2 and the plates incu-
bated for 1 hr at room temperature (RT). The
presence  of  antigen  specific  antibodies  was
detected with horse radish peroxidase (HRP)
conjugated  goat  anti-mouse  IgG  (Caltag,
Hamburg, Germany) diluted 1:2000. One-hun-
dred ʼL of 3,3’,5,5’-tetramethylbenzidine (TMB)
(Kem-En-Tec,  Copenhagen,  Denmark)  was
added to each well and the reaction was termi-
nated with 100 ʼL 4 M H3PO4. The absorbance of
the ELISA plates was read at 450 and 620 nm. 
Isotyping and antibody purification
The isotypes of the antibodies were deter-
mined using the Mouse Monoclonal Antibody
Isotyping Kit (Boehringer Mannheim, Hvidovre,
Denmark),  according  to  the  manufacturer’s
instructions. The antibodies were purified from
culture  supernatant  using  a  protein  A
Sepharose  4  Fast  Flow  column  (Amer  sham
Biosciences, Uppsala, Sweden). The pH of the
filtered supernatants was adjusted to 8.5 and
the solutions supplemented with 3 M NaCl. The
samples were applied to the column, initially
equilibrated and subsequently washed with 50
mM Tris, 3.5 M NaCl, pH 8.5. Elution was per-
formed  with  25  mM  Citric  acid,  4.5  mM  Tri-
natrium-citrate and pH 3. The pooled eluates
were dialyzed against phosphate buffered saline
(PBS) and 0.05% NaN3 was added to the puri-
fied antibodies.
Immunohistochemistry
In  general,  animal  sera,  hybridoma  super-
natants and purified antibodies against Pdx1
were analysed by immunohistochemical stain-
ing  on  frozen  sections  of  adult  murine  pan-
creas. Tissue was fixed in 4% PFA O/N, cryo-pro-
tected by O/N incubation in 30% sucrose and
finally embedded in Tissue-Tek. Ten µm sec-
tions were cut and stored at -80°C. For antigen
retrieval, the sections were soaked in 200 mL
0.01M Citrate buffer and microwaved for 4 min
at 600W, followed by 15 min at 250W and finally
left cooling for 20 min. The tissue sections were
rinsed in PBS, treated with 3% H2O2 for 5 min
and  rinsed  again.  TNB  blocking  buffer  was
added  and  the  sections  blocked  for  30  min,
before  O/N  incubation  with  the  mouse  anti-
Pdx1 antibodies at a concentration of 0.5 µg/mL,
diluted  1:5000  in  TNB  blocking  buffer.  For
absorption  studies,  the  anti-Pdx1  antibodies
were pre-incubated with GST-Pdx1 or the GST-
Nkx6.1  before  use,  as  described  by  previous
studies.
28,32 The sections were washed 3ﾥ5 min
in PBS between the incubations with primary
antibody  and  the  following  incubations  with
biotinylated  secondary  anti  mouse  antibody
(Zymed) for 30 minutes and streptavidin-perox-
idase conjugate (Zymed) for 15 minutes. The
bound antibodies were visualized with the Cy3
fluorophore  tyramide  signal  amplification
(TSA) agent (PerkinElmer) diluted 1:100, after
a 10 min incubation period and a subsequent
wash  in  PBS.  Double  staining  with  antisera
raised  against  Pdx1  in  different  species  was
performed with relevant mouse anti-Pdx1 clone
and  rabbit  anti-Pdx1  1858.5,  1:800.
29 Triple
staining experiments were performed by first
adding  Pdx1  antibody  and  developing  it  with
Cy3- TSA, then incubating with guine  apig-anti-
insulin 1:100 (Abcam, ab7842) and rabbit anti
glucagon 1:300 (DAKO, A0565), visualized by
donkey anti guineapig-Cy2 and donkey anti rab-
bit-Cy5  (Jackson  Immuno  research).  Whole
mount  stains  were  done  as  described  by
Ahnfelt-Ronne J et al.
33 Mouse anti-Pdx1 (F6)
1:700,  guineapig  anti-glucagon  1:4000,  goat
anti-Pdx1 1:15000 (kind gift from Chris Wright)
and developed with donkey anti rabbit-Cy3, don-
key anti-guinea pig-Cy2 and donkey anti-goat-
Cy5. Images were collected with on a Zeiss LSM
510 META confocal microscope.
Nuclear extracts
The SV40 large T-antigen transformed βTC6
insulinoma cells
34 and αTC1.9
35 were grown in
DMEM (glucose 1g/L) supplemented with 1%
glutamax 5% FCS, 20 mM Hepes, 10 µM 2-mer-
captoethanol  and  1%  glutamax,  10  %  FCS,
respectively.  Nuclear  extracts  from  the  cells
were generated from cells harvested by trypsi-
nation.  Cell  pellets  were  lysed  in  1  mL  lysis
buffer (10 mM Hepes pH 7.9, 10 mM KCL, 0.1
mM EDTA and 0,1% Nonidet P40 [NP40], sup-
plemented with the protease inhibitor cocktail
containing 1 mM AEBSF, 1 mM DTT, 10 µg/mL
Aprotinin,  10  µg/mL  Leupeptin  and  1  µg/mL
Pepstatin A). The cell extract was vortexed and
incubated on ice for 45 min. After centrifuga-
tion,  the  pellet  was  re-suspended  in  20  mM
Hepes pH 7.9, 0.4M NaCl and 1 mM EDTA sup-
plemented  with  protease  inhibitor  cocktail.
After five min incubation on ice, the extract was
centrifuged  and  the  protein  concentration  of
the supernatant was measured by the Bradford
method  (Bio-Rad  Laboratories,  Herlev,
Denmark).
Western blots
Purified GST-Pdx1 fusion protein or 10 µg of
nuclear extract was heated for 10 min at 70°C in
sample  buffer  and  loaded  onto  NuPAGE  SDS
PAGE  gels,  run  alongside  the  MagicMark  XP
Standard (Invitrogen, Taastrup, Denmark). The
proteins  were  blotted  onto  a  nitrocellulose
membrane  using  the  NuPAGE  4-morpholine-
propanesulfonic  acid  (MOPS)  buffer  system.
The membrane was washed in PBS 0.1%Tween
and  blocked  for  1  hr  at  RT  in  Amersham
Membrane blocking agent NIF833. 5% w/v in
PBS  0.1%  Tween.  The  monoclonal  anti-Pdx1
antibodies were diluted to a concentration of 1
ʼg/mL before O/N incubation with the mem-
brane  at  4°C.  A  HRP-conjugated  rabbit  Anti-
Mouse  IgG  (DakoCytomation,  Glostrup,
Denmark) was used as the secondary antibody
at a dilution of 1:5000, for 1 hr at RT. Chemi  -
luminescence  was  detected  using  the  ECL
analysis  system  (Amersham  Biosciences,
Uppsala,  Sweden)  and  developed  with  a  LAS
3000 from FUJI FILM.
Pdx1 induction
INSrαβ-Pdx1
22 cells,  passage  38-42,  were
stimulated for 24 hours in medium (RPMI 1640
supplied with 10% Fetal Bovine Serum (Gibco),
1% Penicillin/Streptomycin (Gibco) and 50 ʼM
β-mercaptoethanol  (Sigma)  with  500  ng/mL
doxycycline (Dox) (Sigma). Cells were rinsed
for 5 min in PBS w/o Ca
2+/Mg
2+ and for one hour
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in fresh medium without Dox. The cells were
then  given  fresh  medium  without  Dox.  Cells
were harvested 0, 4, 24, 28, 32, 48, 60 and 72
hours  after  stimulation  with  0.05%  Trypsin-
EDTA (Gibco) and fixated for 20 minutes in 4%
paraformaldehyde  (Lilly’s  fixative)  (VWR
International). 
Pdx1 stainings for FACS analysis
For each time point, 10
6 fixed cells were per-
meabilised by 0.03% Triton X-100 (Sigma) in
PBS  w/o  Ca
2+/Mg
2+ supplemented  with  0.1%
Bovine Serum Albumin (BSA) (Sigma) for one
hour. In order to block unspecific binding, 10%
donkey serum (Jackson) was added for addi-
tionally  one  hour.  Cells  were  then  incubated
overnight  with  mouse  monoclonal  anti-Pdx1
antibody (F6A11) diluted to a final concentra-
tion of 5.00 ʼg/mL, or mouse IgG1k (Abcam)
diluted to a final concentration of 5.00 ʼg/mL.
Rabbit  anti-Pdx1  serum  (1858.5)  or  non-
immune rabbit serum were tested at dilutions
of 1:1000 and 1:5000. The cells were washed
three times in PBS + 0.1% BSA, then incubated
with a Cy2 conjugated donkey anti-mouse anti-
body  or  a  Cy2  conjugated  donkey  anti-rabbit
antibody  (both  Jackson  ImmunoResearch)
diluted  1:300,  for  one  hour.  Cells  were  then
washed three times in PBS + 0.1% BSA and
analyzed  on  a  FACS  Aria  flow  cytometer
(Beckton-Dickinson).  Data  analysis  was  per-
formed using FCS Express Version 3 (De Novo
Software).
Real-time qPCR
After  stimulation  with  Dox,  total  RNA  was
extracted from the INSrαβ-Pdx1 cells and cDNA
was  prepared  using  reverse  transcription,  as
described  by  the  manufacturer  (TaqMan  RT
reagents, Applied Biosystems, Foster City, CA,
USA). The expression levels of the genes were
analysed by use of TaqMan assays (Assay ID:
Rat  Pdx1  Rn00755591_m1,  Mouse  Pdx1
Mm00435565_m1,  Rat  Ppia  Rn00690933_m1,
Applied Biosystems) and samples were run on a
TaqMan 7900HT system (Applied Biosystems).
The expression level of the gene of interest was
normalised  against  the  expression  of  the
housekeeping gene peptidylprolyl isomerase A
(Ppia) and evaluated using the delta-delta Ct
method.
36
Image capturing and handeling
All immunofluorescence images were record-
ed  on  a  LSM510  confocal  microscope  (Carl
Zeiss; Brock & Michelsen, Birkerød, Denmark).
Image manipulations were performed using lin-
ear adjustments over the entire image in LSM
Zeiss viewer and Adobe Photoshop.
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Figure 1. GST-Pdx1 is of expected size and the monoclonal antibodies F6 and F109 recog-
nize Pdx1 from βTC6 with correct size; furthermore, F6 and F109 specifically recognize
Pdx1 in adult mouse pancreas. (A) SDS PAGE analysis of the purified GST-Pdx1 fusion pro-
tein, demonstrating the size and purity of the antigen. For the non-reduced protein a double
band around 37 kDa is observed (lane 1), whereas under reducing conditions only a single
band around 38 kDa is seen (lane 2). In addition, a minor band of approximately 70 kDa is
present, which may represent a dimer (filled-in arrowhead). Western blotting of the GST-
Pdx1 using the monoclonal anti-Pdx1 antibody F6 revealed that both bands seen on the SDS
PAGE gel were derived from the Pdx1 fusion protein (lane 3). The hollow arrow head point
to the 70 kDa that is also recognized by F6. (B) Western blot analysis of the purified Pdx1
antibodies F109 (lane 1 and 2) and F6 (lane 3 and 4) for binding to nuclear extracts from
βTC6 cells (lane 2 and 4) and αTC1.9 cells (lane 1 and 3) at 10 ug/well, demonstrating that
the anti-Pdx1 antibodies identify a single band around 39 kDa corresponding to the Pdx1
protein. This binding could be absorbed with the GST-Pdx1 protein, but not with an irrele-
vant GST fusion protein (data not shown). (C, D) Immunohistochemical staining of frozen
adult mouse pancreas with the purified monoclonal antibodies F6 (C, E and G) and F109
(D, F and H) result in nuclear reactivity in the endocrine islets of Langerhans (C and D).
This staining was absorbed by preincubation of the antibodies with the GST-Pdx1 fusion
protein – islet is outlined by broken line (E and F), but not by an irrelevant GST fusion pro-
tein (G and H). The magnification of histochemical stainings is the same. Scale bar is 50 µm.[European Journal of Histochemistry 2010; 54:e19] [page 95]
Results 
A  detailed  understanding  of  the  dynamic
changes in Pdx1 levels in the INSrαβ-Pdx1 cell
line after induction of Pdx1 is vital to data inter-
pretation from this system. To characterize it,
we induced INSrαβ-Pdx1 with Dox for 24 hours,
washed the Dox out and followed the cells for
further 48 hours. To obtain a quantitative meas-
ure of Pdx1 levels in the INSrαβ-Pdx1 cell line,
we assayed Pdx1 levels by FACS on permeabi-
lized  cells.  Using  the  validated  1858.5  rabbit
anti-Pdx1 antiserum,
29 we were unable to detect
a shift in fluorescence after 24 hours of Dox
induction.  However,  using  the  1858.5  rabbit
anti-Pdx1 antiserum on INSrαβ-Pdx1 cells in
immunocytochemistry (ICC) did result in clear
nuclear Pdx1 staining (data not shown). This is
likely due to the use of antiserum instead of the
monoclonal antibodies that are usually utilized
in  FACS  experiments  with  success.  However,
since  no  good  monoclonal  antiPdx1  antibody
was available, we set out to generate one.
Monoclonal antibodies against the Pdx1 tran-
scription factor were generated by immunising
RBF mice with a GST-Pdx1 fusion protein, con-
taining the 68 amino acids of the C-terminal
fragment of rat Pdx1 protein (aa 215-283). We
have previously used this fusion-construct
27 to
generate a series of high-titered rabbit antisera,
some of which showed cross-reaction to both
mouse and human Pdx1.
15,28,29 The expected size
of the GST-Pdx1 fusion protein is ~37 kDa. The
purified protein is observed as a double band
around 37 kDa (Figure 1A, lane 1), which how-
ever  could  be  reduced  to  a  single  band  of
approximately  the  expected  molecular  weight
(Figure 1A, lane 2). In addition, a band of ~70
kDa was observed (Figure 1A, lane 1 filled-in
arrow head). This larger band may represent a
dimer,  as  another  anti-Pdx1  antibody,  when
analyzed by western blotting (Figure 1A, lane 3
hollow arrow head), also recognized it.
Three out of four mice responded to immu-
nization  with  antibody  titers  higher  than
1:36.450, as determined by binding to the GST-
Pdx1 fusion protein in direct ELISA. However,
only one of the sera stained a sub-population of
cells on sections of adult mouse pancreas at a
dilution  of  1:100,  corresponding  to  the  β-cell
population. Thus, this mouse was selected as
the best starting material for hybridoma gener-
ation, to develop monoclonal antibodies against
Pdx1 that could be used primarily for FACS but
also for other immuno-techniques.
The resulting hybridomas were screened for
the selective binding to Pdx1, by binding to the
rat GST-Pdx1 fusion protein vs GST in direct
ELISA.  Subsequently,  the  74  most  positive
clones were further screened for staining of PFA
fixed, frozen sections of adult mouse pancreas,
by immunohistochemstry. Five hybridomas pro-
duced very strong signals, whereas further four
gave weaker signals. Additional subcloning of
the cells resulted in two stable hybridomas pro-
ducing high affinity mouse monoclonal antibod-
ies against Pdx1, termed F6A11 and F109-D12
(hereafter: F6 and F109). These two hybridomas
were produced in large scale and the antibodies
purified from the cell culture supernatant using
protein A. The antibodies produced by both the
F6 and F109 hybridomas were determined to be
of the IgG1/κ subtype (data not shown).
Both the monoclonal anti-Pdx1 antibodies F6
and  F109  were  shown  to  recognize  the  GST-
Pdx1 antigen by western blotting (Figure 1A,
lane 3, and data not shown). In addition, the
antibodies stained a band of 39 kDa, correspon-
Original paper
Figure 2. Monoclonal immunoreactivity co-localize with immunoreactivity generated by val-
idated anti-Pdx1 sera on sections and in whole mount IHC, and co-localize with β-cells, but
not α-cells. Staining of adult pancreas with the monoclonal anti-Pdx1 antibodies F6 (B) and
F109 (E) showed a high degree of overlap with the previously described 1858.5 anti-Pdx1
antiserum (A and D), as seen in C and F (double exposures). Whole-mount triple staining of
the e10.5 budding stage of pancreas development (G-I) by confocal microscopy: Polyclonal
goat anti-Pdx1 (green channel, G); F6 monoclonal anti-Pdx1 (red channel, H); guinea-pig
anti glucagon (blue channel in I). Again almost complete immunoreactive overlap in the pan-
creatic domain is observed between the monoclonal F6 and the goat anti-Pdx1 antiserum (H
vs G) – also visualized as yellow in overlay (I). It is also evident that all glucagon positive cells
(I, blue cells) are devoid of Pdx1 immunoreactivity. Double- (J, K) or triple-staining (L) of
frozen adult mouse pancreas with the monoclonal anti-Pdx1 antibodies F6 (J and L) and
F109 (K) with anti-insulin antibody (J, K, L green) and anti-glucagon antibody (L, blue).
The  monoclonal  anti-Pdx1  antibodies  recognize  islet  nuclei  in  the  mature  islet  β-cells
expressing insulin in the cytosol, but not the glucagon producing α-cell. Scale bars: 50 µm
except panel l, which is 25 µm.[page 96] [European Journal of Histochemistry 2010; 54:e19]
ding to the Pdx1 protein, in nuclear extracts
from  the  SV40  large  T-antigen  transformed
mouse insulinoma βTC6 cell line (Figure 1B,
lane 2 and 4), but not from the αTC1.9 gluca -
gonoma mouse cell line (Figure 1B, lane 1 and
3). This again reflects the expected expression
of  Pdx1  in  these  two  islet  tumor  lines.  This
Western-blot staining specificity of F6 and F109
was confirmed by pre-absorption studies, where
only pre-incubation with GST-Pdx1 fusion pro-
tein and not GST-Nkx6.1 was able to abolish the
appearance  of  the  39  kDa  band  (data  not
shown).
The  purified  monoclonal  mouse  anti-Pdx1
antibodies F6 and F109 were further character-
ized  by  staining  of  frozen  sections  of  adult
mouse pancreas and fetal pancreas. Both anti-
bodies were demonstrated to specifically stain
the nuclei of a sub-population of cells in the
endocrine islets of Langerhans, as expected for
a Pdx1 reactive antibody (Figure 1, C and D).
Specificity was demonstrated as the staining of
the cell nuclei was eliminated by pre-absorption
of the antibodies with the GST-Pdx1 fusion pro-
tein (Figure 1, E and F), but not by pre-absorp-
tion  with  an  irrelevant  GST  fusion  protein
(Figure 1, G and H). Furthermore, double stain-
ing of adult pancreas with a rabbit anti-Pdx1
antiserum (1858.5)
29 demonstrated a near com-
plete overlap of the nuclei recognized by the two
antibodies  (Figure  2A-C  and  D-F).  On  close
inspection of the co-stain (Figure 2 A-F) and
other data (not shown), we found that the F6
monoclonal antibody was superior regarding: i)
less background and more consistent perform-
ance in IHC and ii) an apparent better growth-
rate of the hybridoma. We thus went on to fur-
ther characterize this antibody and performed
triple staining of mouse e10.5 tissue with F6,
goat  anti-Pdx1  and  guinea-pig  anti-glucagon.
This again confirmed that F6 and goat anti-Pdx1
stain  in  overlapping  patterns  (Figure  2G-I).
However,  the  goat  serum  appears  to  give  a
stronger signal in the duodenum and stomach
(Figure 2G-I). Co-staining of adult mouse pan-
creas  for  Pdx1,  insulin  and  glucagon,  clearly
demonstrated the expected β-cell specific stain-
ing pattern, as insulin positive cells are positive
for Pdx1 immunoreactivity (Figure 2J-K), while
glucagon positive cells are not (blue) (Figure
2L). The antibodies were also shown to react
with rat Pdx1, but they did not recognize Pdx1
from  human  tissue  (data  not  shown).
Furthermore,  the  antibodies  worked  equally
well on frozen/fixed or paraffin sections as well
as by using Lilly’s fixative (data not shown).
Finally, the antibodies were efficient when used
in  a  standard  indirect  immunofluorescence
experiments; i.e. without the use of TSA ampli-
fication (data not shown).
Having generated and validated monoclonal
antibodies to Pdx1, we then wanted to test if
they were useful for assaying Pdx1 protein lev-
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Figure 3. Dynamic induction and negative feedback regulation of Pdx1 levels in INSrαβ-
Pdx1. The induction of Pdx1 in INSrαβ-Pdx1 cells is followed by FACS analysis using the
monoclonal antibody F6 (A, B, and C). A rapid induction of Pdx1 by Dox can be seen with
a clear increase in fluorescence intensity from 0 hours (red line) to 4 hours (blue line) before
the Pdx1 level peaks after 24 hours (purple line) (A). Following removal of Dox, the Pdx1
level slowly begins to decline, which can be seen after 28 hours (red line) (4 hours after
removal of Dox) (B). The Pdx1 level continues to decline from 28 hours (red line) to 32 hours
(blue line) (8 hours after removal of Dox), before eventually reaching the lowest point after
48 hours (purple line) (24 hours after removal of Dox) (B). Slowly, from 48 hours (purple
line (B)) to 60 hours (red line (C)) (36 hours after removal of Dox) and through to 72 hours
(blue line (C)) (48 hours after removal of Dox), the Pdx1 level recovers and gradually
approaches the initial level found at 0 hours (red line (a)). Panel a-c constitutes a single exper-
iment, representative of three independent experiments. The bars in figure G represent aver-
ages of the relative Pdx1 levels found in the three independent experiments. Student’s T-test
assuming unequal variances was applied to test whether Pdx1 levels at the time points were
different to the level at 0 hours”*” or 24 hours (time of Dox removal)”#”. *P<0.05, **P<0.01,
#P<0.05, ##P<0.01, ###P<0.005. Confocal microscopical analysis of the samples analysed
on the FACS and later supplied with DNA binding fluorophore DAPI confirm the FACS data
(D, E and F). The images reveal a visible increase in Pdx1 from 0 hours (D) to the peak at 24
hours (E) and clear decline to 48 hours (F). Error bars are sd.[European Journal of Histochemistry 2010; 54:e19] [page 97]
els  in  individual  cells  by  intracellular  FACS
analysis. To this end, INSrαβ-Pdx1 cells were
induced with Dox for 24 h and Pdx1 levels were
analysed at 0 h, 4 h and 24 h by FACS. The Dox
was then washed out and, the cells were fol-
lowed for additionally 48 h and tested in FACS at
4, 8, 24, 36 and 48 h post-wash. A fast and sig-
nificant  rise  in  mean  fluorescence  intensity
was observed already after 4 h, reaching a 2.3-
fold increase compared with control levels at 24
h (Figure 3A and G). Increase in Pdx1 levels was
confirmed  by  western  blotting  (data  not
shown).  Pdx1  levels  declined  significantly
already 8 h after removal of Dox and a further
reduction was observed 24 h after Dox removal.
At this time, the Pdx1 level had been reduced
3.4-fold compared with the maximum levels 24
h after addition of Dox. Surprisingly, Pdx1 levels
were reduced significantly below starting levels
24 h after removal of Dox. However, the reduc-
tion in Pdx1 levels observed at 24 h after Dox
removal was normalized after additional 24 h
(Figure 3 G). In order to confirm that the fluo-
rescence-signal observed by FACS reflected an
immunoreaction to Pdx1, we investigated the
staining in the microscope and found a convinc-
ing nuclear staining at 24 h after induction with
Dox  (Figure  3E).  Furthermore,  the  strong
induction of Pdx1 was confirmed by comparing
the immunoreaction before and after induction
(Figure 3 D vs.E). The observed decline in Pdx1
levels at 24 h was confirmed by fluorescence
microscopy  when  comparing  this  time  point
with cells before induction (Figure 3D vs. F). 
To investigate whether the observed reduc-
tion  in  Pdx1  levels  24  h  after  Dox  removal
(Figure 3F and G) might reflect a reduction in
the synthesis of endogenous rat Pdx1, we per-
formed  qPCR  for  mouse  (induced)  and  rat
(endogenous) Pdx1 mRNA at 24 h after induc-
tion, the time point where total Pdx1 protein
level peaks. This analysis showed that mouse
Pdx1 mRNA was up-regulated 28-fold (Figure 4,
black). In contrast, rat Pdx1 mRNA was reduced
by 3 fold (Figure 4, grey). To rule out a general
reduction of all endogenous genes upon induc-
tion with Dox, qPCR was performed for several
other mRNAs. The other profiled genes did not
show  any  significant  differential  regulation
(data not shown). 
Discussion
The  two  new  Pdx1-specific  monoclonal
mouse antibodies, F6 and F109, could hence be
added  to  our  previously  published  panel  of
reagents for the immunohistochemical detec-
tion of critical pancreatic transcription factors
including  Ngn3,
37 Nkx6.1
32 and  Ptf1a.
38 These
monoclonals are important tools for investiga-
tions aimed at understanding the mechanisms
of  pancreatic  development  from  the  earliest
budding  stages  to  the  final  differentiation  of
mature insulin secreting β-cells. In particular,
they will be of great value in FACS studies and
for  multi-label  immunohistochemistry.  Poly  -
clonal antisera against Pdx1 have been avail-
able for more than 10 years and to our knowl-
edge F6 and F109 represent the first monoclon-
al anti-Pdx1 antibodies useful for FACS as well
as for immunohistochemical applications.
In this study, we used the F6 monoclonal anti-
body to characterize the induction of Pdx1 pro-
tein in INSrαβ-Pdx1 cells by fluorescence-acti-
vated cell sorting (FACS) analysis. Our FACS
results  show  that  the  fluorescence  intensity
before induction follows a normal distribution
as expected for a homogenous cell population.
After induction with Dox, the normal distribu-
tion of the fluorescence intensity is maintained
as the mean fluorescence intensity increases
and subsequently decreases, indicating that the
entire  INSrαβ-Pdx1  cell  population  responds
homogenously. Furthermore, our FACS results
show that Pdx1 is induced within hours after
addition of Dox and continues to increase up to
24 h. Removal of Dox results in a decrease in
Pdx1 levels, which reach their lowest point 24 h
after removal of Dox. Surprisingly, at this point
we  find  Pdx1  levels  to  be  significantly  lower
than before Dox stimulation (0 h), indicating a
possible negative feedback loop. A substantial
amount of existing literature shows that Pdx1
can bind to its own promoter sequence
21,39,40 and
a role for Pdx1 in controlling its own promoter
activity through a positive feedback mechanism
has previously been suggested.
20,40 However, our
finding that Pdx1 has a repressive effect upon
its own expression is further supported by qPCR
data that show a 3-fold decline in endogenous
Pdx1 mRNA 24 h after induction with Dox. This
3-fold decline in endogenous Pdx1 mRNA could
be due to general squelching resulting from the
over expression of mouse Pdx1 by addition of
Dox. However, an array study was performed on
the INSrαβ-Pdx1 cells to exclude this possibili-
ty. Twenty six hours after induction with Dox,
16% of the probe sets were differentially regu-
lated and 48 hours after induction, only 12% of
the probe sets were differentially regulated (H.
Bang-Berthelsen,  manuscript  in  preparation).
Among the differentially regulated genes, there
are many genes expected to be regulated nega-
tively or positively by Pdx1, substantiating the
validity of the system. Yet, further studies are
needed to clarify the mechanism of this novel
negative feedback loop. We propose a model in
which increased amounts of Pdx1 protein lead
to an up-regulation of a negative regulator of
the Pdx1 gene, resulting in the normalization of
Pdx1 protein levels.
The  availability  of  these  new  monoclonal
antibodies through the Developmental Studies
Hybridoma  Bank  (http://dshb.biology.
uiowa.edu) will aid such studies.
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